Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

被引:241
|
作者
Bonome, T
Lee, JY
Park, DC
Radonovich, M
Pise-Masison, C
Brady, J
Gardner, GJ
Hao, K
Wong, WH
Barrett, JC
Lu, KH
Sood, AK
Gershenson, DM
Mok, SC
Birrer, MJ
机构
[1] NCI, Cell & Canc Biol Branch, Canc Res Ctr, Bethesda, MD 20892 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Lab Gynecol Oncol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[4] Stanford Univ, Dept Stat, Stanford, CA 94305 USA
[5] Univ Texas, MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA
关键词
D O I
10.1158/0008-5472.CAN-05-2240
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Papillary serous low malignant potential (LMP) tumors are characterized by malignant features and metastatic potential yet display a benign clinical course. The role of LMP tumors in the development of invasive epithelial cancer of the ovary is not clearly defined. The aim of this study is to determine the relationships among LMP tumors and invasive ovarian cancers and identify genes contributing to their phenotypes. Affymetrix U133 Plus 2.0 microarrays (Santa Clara, CA) were used to interrogate 80 microdissected serous LMP tumors and invasive ovarian malignancies along with 10 ovarian surface epithelium (OSE) brushings. Gene expression profiles for each tumor class were used to complete unsupervised hierarchical clustering analyses and identify differentially expressed genes contributing to these associations. Unsupervised hierarchical clustering analysis revealed a distinct separation between clusters containing borderline and high-grade lesions. The majority of low-grade tumors clustered with LMP tumors. Comparing OSE with high-grade and LMP expression profiles revealed enhanced expression of genes linked to cell proliferation, chromosomal instability, and epigenetic silencing in high-grade cancers, whereas LMP tumors displayed activated p53 signaling. The expression profiles of LMP, low-grade, and high-grade papillary serous ovarian carcinomas suggest that LMP tumors are distinct from high-grade cancers; however, they are remarkably similar to low-grade cancers. Prominent expression of p53 pathway members may play an important role in the LMP tumor phenotype.
引用
收藏
页码:10602 / 10612
页数:11
相关论文
共 50 条
  • [31] Endocrine biomarkers in low-grade serous ovarian cancers (LGSC) and serous ovarian tumors of low malignant potential (LMP).
    Taylor, Sarah E.
    Wield, Alyssa
    Fang, Yusi
    Bhargava, Rohit
    Lang, Susan
    Tseng, George
    Coffman, Lan Gardner
    Oesterreich, Steffi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [32] Pseudoprogression Occurs in Children with Both Low-grade and High-grade Tumors
    Chawla, S.
    Mangla, M.
    Mangla, R.
    Muhs, A.
    Ekholm, S.
    Korones, D.
    Constine, L. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S39 - S39
  • [33] STATUS OF CONTRALATERAL OVARY IN ENCAPSULATED LOW-GRADE MALIGNANT-TUMORS OF OVARY
    WILLIAMS, TJ
    DOCKERTY, MB
    SURGERY GYNECOLOGY & OBSTETRICS, 1976, 143 (05): : 763 - 766
  • [34] LOW-GRADE WATER FOR HIGH-GRADE INDUSTRY
    不详
    EFFLUENT & WATER TREATMENT JOURNAL, 1967, 7 (06): : 333 - &
  • [35] Ovarian Serous Tumors of Low Malignant Potential with Nodal Low Grade Serous Carcinoma.
    Djordjevic, B.
    Malpica, A.
    LABORATORY INVESTIGATION, 2011, 91 : 243A - 243A
  • [36] CYTOLOGIC FINDINGS OF BORDERLINE (LOW-GRADE) MALIGNANT-TUMORS OF THE OVARY
    KANBOUR, A
    WAGNER, J
    COMMISSO, J
    ACTA CYTOLOGICA, 1981, 25 (04) : 448 - 448
  • [37] Qualitative Age Interactions between Low-grade and High-grade Serous Ovarian Carcinomas
    Grimley, Philip M.
    Matsuno, Rayna K.
    Rosenberg, Philip S.
    Henson, Donald E.
    Schwartz, Arnold M.
    Anderson, William F.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (08) : 2256 - 2261
  • [38] A data science approach for the classification of low-grade and high-grade ovarian serous carcinomas
    Sangdi Lin
    Chen Wang
    Shabnam Zarei
    Debra A. Bell
    Sarah E. Kerr
    George C. Runger
    Jean-Pierre A. Kocher
    BMC Genomics, 19
  • [39] A data science approach for the classification of low-grade and high-grade ovarian serous carcinomas
    Lin, Sangdi
    Wang, Chen
    Zarei, Shabnam
    Bell, Debra A.
    Kerr, Sarah E.
    Runger, George C.
    Kocher, Jean-Pierre A.
    BMC GENOMICS, 2018, 19
  • [40] Advancements in Low-Grade Serous Carcinoma of the Ovary and Peritoneum
    Rachel N. Grisham
    M. Herman Chui
    Current Oncology Reports, 2022, 24 : 1549 - 1555